Matsuzawa Shu-ichi

Title: Innovations of Matsuzawa Shu-ichi

Introduction

Matsuzawa Shu-ichi is a prominent inventor based in San Diego, CA (US). He has made significant contributions to the field of protein degradation through his innovative research and patents. His work focuses on the development of novel proteins and methods that have potential applications in therapeutic compositions and drug screening.

Latest Patents

Matsuzawa holds a patent titled "Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto." This invention introduces novel Siah-Mediated-Degradation-Proteins (SMDPs) and/or SCF-Complex Proteins (SCPs). The patent discloses nucleic acid sequences encoding these proteins and various assays employing them. The SMDPs and SCPs can be utilized for producing anti-SMDP and/or SCP antibodies, as well as in therapeutic compositions and methods for drug screening and functional genomics. Additionally, the invention includes transgenic non-human mammals that express the proteins.

Career Highlights

Matsuzawa Shu-ichi is affiliated with the Sanford-Burnham Medical Research Institute, where he conducts his research. His work has led to advancements in understanding protein degradation mechanisms, which are crucial for various biological processes.

Collaborations

Matsuzawa collaborates with notable colleagues, including John C. Reed, enhancing the impact of his research through shared expertise and resources.

Conclusion

Matsuzawa Shu-ichi's innovative contributions to the field of protein degradation exemplify the importance of research in developing therapeutic applications. His patent and ongoing work continue to influence advancements in functional genomics and drug discovery.